
miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer
Keywords: سرم جنینی گاوی; miRNAs, MicroRNAs; BC, breast cancer; VEGFA, vascular endothelial growth factor a; IRS1, Insulin receptor substrate 1; HIPAA, Health Insurance Portability and Accountability Act; DMEM, Dulbecco’s Modified Eagle Medium; FBS, fetal bovine serum; MEM, Minimu